Fortis Advisors’s Encompass Health EHC Stock Holding History

Fortis Advisors’s Portfolio EHC Stock Details EHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-3,057	Closed	-$150K	–	322
2018 Q4	$150K	Buy	+3,057	New	+$174K	0.09%	136

Other funds holding EHC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Fortis Advisors's EHC Position: Q1 2019 in Review

Fortis Advisors sold out of Encompass Health (EHC) in Q1 2019, closing a stake of 3,057 shares — an estimated $150K sold.

Fortis Advisors first reported a position in EHC in Q4 2018 and held it in 1 quarter. The position peaked at $150K in Q4 2018. 427 funds tracked by Wall St. Rank hold EHC as of Q1 2019.

Fortis Advisors reported no remaining Encompass Health position as of Q1 2019 after selling out during the quarter.
Fortis Advisors sold 3,057 Encompass Health shares in Q1 2019, an estimated $150K.
Fortis Advisors first reported a position in Encompass Health in Q4 2018 and held it in 1 quarter.
Fortis Advisors's Encompass Health position peaked at $150K in Q4 2018.
427 funds tracked by Wall St. Rank held Encompass Health as of Q1 2019.

Based on Fortis Advisors's 13F filing for Q1 2019, filed 15 May 2019.